How do scientists develop new treatments for disease? With Gleevec, a remarkable cancer drug, the approach was to target the disease at the cellular and subcellular level. When people say Gleevec ...

Get detailed information on Imatinib, including pronunciation ... For further clarification, consult your healthcare provider. This medication is a protein-tyrosine kinase inhibitor, prescribed ...

In 2001, a Time Magazine cover story touted Novartis’ targeted leukemia treatment Gleevec (imatinib) as a new kind of “ammunition in the war against cancer.” Along with a picture of the ...

The oral solution offers precise dosing, benefiting patients with swallowing difficulties or requiring tailored dosing.

He worked with chemists at Novartis to develop a drug that would bind to the mutant protein like a key in a lock. Novartis produced a compound known as imatinib that worked in the test tube.